MML Investors Services’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.52M | Sell |
223,048
-48,453
| -18% | -$2.17M | 0.02% | 655 |
|
|
2026
Q1 | $13.1M | Sell |
271,501
-25,859
| -9% | -$1.21M | 0.04% | 459 |
|
|
2025
Q4 | $14.4M | Buy |
297,360
+29,164
| +11% | +$1.45M | 0.04% | 452 |
|
|
2025
Q3 | $12.7M | Buy |
268,196
+1,221
| +0.5% | +$58.9K | 0.03% | 470 |
|
|
2025
Q2 | $12.9M | Buy |
266,975
+8,669
| +3% | +$443K | 0.04% | 440 |
|
|
2025
Q1 | $14.3M | Buy |
258,306
+16,905
| +7% | +$915K | 0.05% | 374 |
|
|
2024
Q4 | $11.6M | Buy |
241,401
+10,865
| +5% | +$552K | 0.04% | 406 |
|
|
2024
Q3 | $13.3M | Sell |
230,536
-17,716
| -7% | -$956K | 0.05% | 352 |
|
|
2024
Q2 | $12M | Buy |
248,252
+4,657
| +2% | +$225K | 0.05% | 356 |
|
|
2024
Q1 | $11.8M | Buy |
243,595
+18,891
| +8% | +$922K | 0.05% | 360 |
|
|
2023
Q4 | $11.2M | Buy |
224,704
+21,370
| +11% | +$1.04M | 0.05% | 346 |
|
|
2023
Q3 | $10.9M | Buy |
203,334
+19,290
| +10% | +$1.03M | 0.06% | 314 |
|
|
2023
Q2 | $9.92M | Buy |
184,044
+40,356
| +28% | +$2.17M | 0.05% | 327 |
|
|
2023
Q1 | $7.82M | Buy |
143,688
+27,160
| +23% | +$1.32M | 0.06% | 336 |
|
|
2022
Q4 | $5.64M | Buy |
116,528
+23,810
| +26% | +$1.05M | 0.04% | 450 |
|
|
2022
Q3 | $3.52M | Buy |
92,718
+10,361
| +13% | +$462K | 0.03% | 543 |
|
|
2022
Q2 | $4.12M | Buy |
82,357
+6,212
| +8% | +$330K | 0.03% | 487 |
|
|
2022
Q1 | $3.91M | Buy |
76,145
+7,667
| +11% | +$396K | 0.03% | 529 |
|
|
2021
Q4 | $3.43M | Buy |
68,478
+7,794
| +13% | +$386K | 0.02% | 559 |
|
|
2021
Q3 | $2.93M | Buy |
60,684
+8,258
| +16% | +$420K | 0.02% | 586 |
|
|
2021
Q2 | $2.76M | Sell |
52,426
-3,305
| -6% | -$172K | 0.02% | 588 |
|
|
2021
Q1 | $2.76M | Buy |
55,731
+1,351
| +2% | +$64.9K | 0.03% | 544 |
|
|
2020
Q4 | $2.64M | Buy |
54,380
+8,594
| +19% | +$424K | 0.03% | 483 |
|
|
2020
Q3 | $2.3M | Buy |
45,786
+2,630
| +6% | +$135K | 0.03% | 473 |
|
|
2020
Q2 | $2.2M | Buy |
43,156
+788
| +2% | +$38.3K | 0.03% | 465 |
|
|
2020
Q1 | $1.85M | Buy |
42,368
+3,509
| +9% | +$168K | 0.03% | 445 |
|
|
2019
Q4 | $1.95M | Buy |
38,859
+6,690
| +21% | +$313K | 0.03% | 491 |
|
|
2019
Q3 | $1.49M | Sell |
32,169
-46
| -0.1% | -$1.98K | 0.02% | 541 |
|
|
2019
Q2 | $1.39M | Buy |
32,215
+3,389
| +12% | +$144K | 0.02% | 603 |
|
|
2019
Q1 | $1.28M | Sell |
28,826
-471
| -2% | -$20.2K | 0.02% | 614 |
|
|
2018
Q4 | $1.27M | Buy |
29,297
+4,391
| +18% | +$194K | 0.02% | 578 |
|
|
2018
Q3 | $1.11M | Sell |
24,906
-16,719
| -40% | -$714K | 0.02% | 635 |
|
|
2018
Q2 | $1.67M | Buy |
41,625
+4,337
| +12% | +$171K | 0.04% | 411 |
|
|
2018
Q1 | $1.5M | Buy |
37,288
+118
| +0.3% | +$4.91K | 0.03% | 418 |
|
|
2017
Q4 | $1.6M | Sell |
37,170
-2,497
| -6% | -$115K | 0.03% | 399 |
|
|
2017
Q3 | $1.98M | Buy |
39,667
+13
| +0% | +$629 | 0.04% | 335 |
|
|
2017
Q2 | $1.9M | Buy |
39,654
+6,215
| +19% | +$297K | 0.04% | 335 |
|
|
2017
Q1 | $1.5M | Buy |
33,439
+27,234
| +439% | +$1.16M | 0.03% | 197 |
|
|
2016
Q4 | $251K | Buy |
+6,205
| New | +$244K | 0.28% | 39 |
|
Other funds holding SNY
MIP
EIC
DC
TAM
MML Investors Services's SNY Position: Q2 2026 in Review
MML Investors Services reduced its Sanofi (SNY) stake by 18% in Q2 2026, selling an estimated $2.17M and leaving 223,048 shares worth $9.52M. The position accounts for 0.02% of the portfolio, ranked #655.
MML Investors Services first reported a position in SNY in Q4 2016 and has held it in 39 quarters since. The position peaked at $14.4M in Q4 2025. 404 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- MML Investors Services held 223,048 shares of Sanofi worth $9.52M as of Q2 2026.
- MML Investors Services sold 48,453 Sanofi shares in Q2 2026, an estimated $2.17M.
- Sanofi made up 0.02% of MML Investors Services's portfolio in Q2 2026, its #655 holding.
- MML Investors Services first reported a position in Sanofi in Q4 2016 and has held it in 39 quarters since.
- MML Investors Services's Sanofi position peaked at $14.4M in Q4 2025.
- 404 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.